...
首页> 外文期刊>Journal of Surgical Oncology >Elevated serum concentration of monocyte chemotactic protein 4 (MCP-4) as a novel non-invasive prognostic and predictive biomarker for detection of metastasis in colorectal cancer
【24h】

Elevated serum concentration of monocyte chemotactic protein 4 (MCP-4) as a novel non-invasive prognostic and predictive biomarker for detection of metastasis in colorectal cancer

机译:升高的单核细胞趋化蛋白4(MCP-4)血清浓度可作为检测结肠直肠癌转移的新型非侵入性预后和预测生物标志物

获取原文
获取原文并翻译 | 示例

摘要

PurposeDespite recent progress in the diagnosis and treatment of colorectal cancer (CRC), the prognosis remains poor, and metastatic recurrence is the leading cause of poor prognosis. We systemically evaluated the levels of differentially-expressed serum cytokines using array-based techniques to identify a novel and reliable serum biomarker with which to predict metastasis and poor outcomes of CRC.
机译:目的尽管在结直肠癌(CRC)的诊断和治疗方面取得了新的进展,但预后仍然很差,转移性复发是预后不良的主要原因。我们使用基于阵列的技术系统评估了差异表达的血清细胞因子的水平,以确定一种新颖且可靠的血清生物标志物,可用来预测CRC的转移和不良预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号